UniProtKB/Swiss-Prot Q12879: Variant p.Lys270Glu

Glutamate receptor ionotropic, NMDA 2A
Gene: GRIN2A
Feedback?

Variant information Variant position:

270 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Glutamate (E) at position 270 (K270E, p.Lys270Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Sequence information Variant position:

270 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1464 The length of the canonical sequence.
Location on the sequence:

GYDFFWIVPSLVSGNTELIP K EFPSGLISVSYDDWDYSLEA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEA

Chimpanzee                    GYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEA

Mouse                         GYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEA

Rat                           GYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEA

Xenopus laevis                GYGFVWIVPSLVTGNTDIIPYEFPSGLVSVSYDDWDYGIEA

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	23 – 1464	Glutamate receptor ionotropic, NMDA 2A
Topological domain	23 – 555	Extracellular
Binding site	266 – 266
Binding site	282 – 282
Disulfide bond	87 – 320

Literature citations
Human N-methyl-D-aspartate receptor modulatory subunit hNR2A: cloning and sequencing of the cDNA and primary structure of the protein.
Foldes R.L.; Adams S.L.; Fantaske R.P.; Kamboj R.K.;
Biochim. Biophys. Acta 1223:155-159(1994)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT GLU-270;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.